MR-based automatic delineation of volumes of interest in human brain PET images using probability maps - PubMed (original) (raw)
Clinical Trial
. 2005 Feb 15;24(4):969-79.
doi: 10.1016/j.neuroimage.2004.10.017. Epub 2004 Dec 9.
Affiliations
- PMID: 15670674
- DOI: 10.1016/j.neuroimage.2004.10.017
Clinical Trial
MR-based automatic delineation of volumes of interest in human brain PET images using probability maps
Claus Svarer et al. Neuroimage. 2005.
Abstract
The purpose of this study was to develop and validate an observer-independent approach for automatic generation of volume-of-interest (VOI) brain templates to be used in emission tomography studies of the brain. The method utilizes a VOI probability map created on the basis of a database of several subjects' MR-images, where VOI sets have been defined manually. High-resolution structural MR-images and 5-HT(2A) receptor binding PET-images (in terms of (18)F-altanserin binding) from 10 healthy volunteers and 10 patients with mild cognitive impairment were included for the analysis. A template including 35 VOIs was manually delineated on the subjects' MR images. Through a warping algorithm template VOI sets defined from each individual were transferred to the other subjects MR-images and the voxel overlap was compared to the VOI set specifically drawn for that particular individual. Comparisons were also made for the VOI templates 5-HT(2A) receptor binding values. It was shown that when the generated VOI set is based on more than one template VOI set, delineation of VOIs is better reproduced and shows less variation as compared both to transfer of a single set of template VOIs as well as manual delineation of the VOI set. The approach was also shown to work equally well in individuals with pronounced cerebral atrophy. Probability-map-based automatic delineation of VOIs is a fast, objective, reproducible, and safe way to assess regional brain values from PET or SPECT scans. In addition, the method applies well in elderly subjects, even in the presence of pronounced cerebral atrophy.
Similar articles
- A probabilistic approach to delineating functional brain regions.
Kalbitzer J, Svarer C, Frokjaer VG, Erritzoe D, Baaré WF, Madsen J, Hasselbalch SG, Knudsen GM. Kalbitzer J, et al. J Nucl Med Technol. 2009 Jun;37(2):91-5. doi: 10.2967/jnmt.108.054056. Epub 2009 May 15. J Nucl Med Technol. 2009. PMID: 19447857 - Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain.
Casteels C, Vermaelen P, Nuyts J, Van Der Linden A, Baekelandt V, Mortelmans L, Bormans G, Van Laere K. Casteels C, et al. J Nucl Med. 2006 Nov;47(11):1858-66. J Nucl Med. 2006. PMID: 17079820 - An automated ROI setting method using NEUROSTAT on cerebral blood flow SPECT images.
Ogura T, Hida K, Masuzuka T, Saito H, Minoshima S, Nishikawa K. Ogura T, et al. Ann Nucl Med. 2009 Jan;23(1):33-41. doi: 10.1007/s12149-008-0203-7. Epub 2009 Feb 11. Ann Nucl Med. 2009. PMID: 19205836 - Deconvolution-based partial volume correction in Raclopride-PET and Monte Carlo comparison to MR-based method.
Tohka J, Reilhac A. Tohka J, et al. Neuroimage. 2008 Feb 15;39(4):1570-84. doi: 10.1016/j.neuroimage.2007.10.038. Epub 2007 Nov 7. Neuroimage. 2008. PMID: 18077187 - The role of anatomic information in quantifying functional neuroimaging data.
Bohm C, Greitz T, Thurfjell L. Bohm C, et al. J Neural Transm Suppl. 1992;37:67-78. doi: 10.1007/978-3-7091-9209-2_6. J Neural Transm Suppl. 1992. PMID: 1402853 Review.
Cited by
- Blood-brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 gene.
van Assema DM, Lubberink M, Rizzu P, van Swieten JC, Schuit RC, Eriksson J, Scheltens P, Koepp M, Lammertsma AA, van Berckel BN. van Assema DM, et al. EJNMMI Res. 2012 Oct 16;2(1):57. doi: 10.1186/2191-219X-2-57. EJNMMI Res. 2012. PMID: 23067778 Free PMC article. - Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala.
Hornboll B, Macoveanu J, Rowe J, Elliott R, Paulson OB, Siebner HR, Knudsen GM. Hornboll B, et al. J Psychopharmacol. 2013 Oct;27(10):903-14. doi: 10.1177/0269881113494106. Epub 2013 Jul 2. J Psychopharmacol. 2013. PMID: 23824248 Free PMC article. Clinical Trial. - Design of Infusion Schemes for Neuroreceptor Imaging: Application to [(11)C]Flumazenil-PET Steady-State Study.
Feng L, Svarer C, Madsen K, Ziebell M, Dyssegaard A, Ettrup A, Hansen HD, Lehel S, Yndgaard S, Paulson OB, Knudsen GM, Pinborg LH. Feng L, et al. Biomed Res Int. 2016;2016:9132840. doi: 10.1155/2016/9132840. Epub 2016 Mar 31. Biomed Res Int. 2016. PMID: 27123457 Free PMC article. Clinical Trial. - Cerebral blood flow and glucose metabolism measured with positron emission tomography are decreased in human type 1 diabetes.
van Golen LW, Huisman MC, Ijzerman RG, Hoetjes NJ, Schwarte LA, Lammertsma AA, Diamant M. van Golen LW, et al. Diabetes. 2013 Aug;62(8):2898-904. doi: 10.2337/db12-1159. Epub 2013 Mar 25. Diabetes. 2013. PMID: 23530004 Free PMC article. - Kinetics and 28-day test-retest repeatability and reproducibility of [11C]UCB-J PET brain imaging.
Tuncel H, Boellaard R, Coomans EM, de Vries EF, Glaudemans AW, Feltes PK, García DV, Verfaillie SC, Wolters EE, Sweeney SP, Ryan JM, Ivarsson M, Lynch BA, Schober P, Scheltens P, Schuit RC, Windhorst AD, De Deyn PP, van Berckel BN, Golla SS. Tuncel H, et al. J Cereb Blood Flow Metab. 2021 Jun;41(6):1338-1350. doi: 10.1177/0271678X20964248. Epub 2020 Oct 8. J Cereb Blood Flow Metab. 2021. PMID: 34013797 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical